<DOC>
	<DOCNO>NCT02448680</DOCNO>
	<brief_summary>The purpose study assess safety , efficacy pharmacokinetics 2 separate dose regimen ( 75µg/kg 225 µg/kg ) Coagulation Factor VIIa ( Recombinant ) treatment bleed episode hemophilia A B patient inhibitor Factor VIII IX 12 patient ( birth &lt; 6 year old ) , 12 patient ( ≥6 year old &lt; 12 year old ) .</brief_summary>
	<brief_title>A Phase III Study Safety , Pharmacokinetics Efficacy Coagulation Factor VIIa</brief_title>
	<detailed_description>A Phase III Study Safety , Pharmacokinetics , Efficacy Coagulation Factor VIIa ( Recombinant ) Congenital Hemophilia A B Pediatric Patients birth &lt; 12 year old Inhibitors Factor VIII IX : PerSept 2</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>male diagnosis congenital hemophilia A B severity one following : positive inhibitor test BU ≥5 , OR Bethesda Unit ( BU ) &lt; 5 expect high anamnestic response FVIII FIX , demonstrate patient 's medical history , preclude use factor VIII IX product treat bleed episode , OR BU &lt; 5 expected refractory increase dose FVIII FIX , demonstrate patient 's medical history , preclude use factor VIII IX product treat bleed episode age birth &lt; 12 year old experience least 3 bleed episode severity past 6 month parent legal guardian must capable understand willing comply condition protocol parent legal guardian must read , understood , provide write informed consent coagulation disorder hemophilia A B immunosuppressed ( i.e. , patient may receive systemic immunosuppressive medication ; cluster differentiation 4 ( CD4 ) count screen must &gt; 200/µL ) know allergy hypersensitivity rabbit platelet count &lt; 100,000/mL major surgical procedure ( e.g . orthopedic , abdominal ) within 1 month prior first administration study drug receive investigational drug within 30 day first study drug administration , expect receive drug participation study</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>